Your English writing platform
Discover LudwigSuggestions(4)
Exact(21)
Both groups received a standard treatment including a symptomatic therapy and a saline therapy.
Hypertonic 3%% saline therapy through intravenous administration is the safest option whenever participants exhibit profound hyponatremia and/or neurological symptoms [236 238].
Volume overload is an obvious contraindication to hypertonic saline therapy, but the great bulk of patients managed for profound, symptomatic hyponatremia usually display normal or diminished ECFV.
Of note, normal saline therapy, routinely deemed as isotonic is in fact hypertonic relatively to the plasma osmolarity of hyponatremic patients.
If decreased ECFV is the prime mechanism underpinning hyponatremia, then intravenous normal saline therapy is the most judicious choice, besides addressing the cause responsible for the contracted EFCV.
0.9 % NaCl is a reasonable first choice treatment but physicians may switch to hypertonic saline therapy (either 1.5 or 3%% NaCl) in case PNa levels fail to increase [214].
Similar(39)
Results All 20 patients received both lidocaine and saline placebo therapy in a crossover manner.
No patients had received colloid, plasma products, hypertonic saline, diuretic therapy or blood transfusion approximately 10 hours before surgery.
All patients received norepinephrine (n = 20), 85% (n = 17) received hypertonic saline, and therapy lasted on average 7.6 days (CI 95%5.66 to 9.5).
In case of hypovolemia and/or cardiogenic shock, saline fluid therapy is started (10 to 20 ml/kg of NaCl 0.9% up to three times during the first one to two hours), which is followed by inotropic therapy if necessary.
In chronic sinusitis additional careful local therapy (saline lavage, expectorant and decongestant therapy) is mandatory.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com